FUBP1 and gastric adenocarcinoma: Nonsignificant differences in survival status between the patients with high and low FUBP1 expression were observed in cancer types such as bladder carcinoma, head-neck squamous cell carcinoma, lung squamous cell carcinoma, ovarian cancer, stomach adenocarcinoma, testicular germ cell tumor, thyroid carcinoma, and uterine corpus endometrial carcinoma (p > 0.05) (Supplementary Figure S6).